At low levels, it exerts a protective effect on hepatic steatosis due to its insulin-sensitizing effects, suppression of gluconeogenesis, and de novo lipogenesis, as well as its stimulation of FFA beta-oxidation [23]. The gene discussed is INS; the disease is fatty liver disease.